Patient was not fit for Docetaxel therapy and he was put on monthly Denosumab injection 120 mg/1 syringe, and Abiraterone ...

Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

Explore the role of the extracellular matrix (ECM) in prostate cancer progression and discover natural therapies, including ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on the rise. In Thailand, it is the 4th most common cancer among men (1), ...

More men are getting checked for prostate cancer and realising they have the disease at an early stage, but charity Prostate ...

In a live event, Vinay Minocha, MD, discusses the addition of darolutamide to androgen deprivation therapy for in patients ...

Evan Y. Yu, MD, discusses the design and objectives of the phase 3 PEACE 3 study, which evaluates the combination of enzalutamide (ENZA) and radium-223 (Ra-223) in androgen receptor pathway inhibitor ...

28, 2025 — A new study shows that asymptomatic brain metastasis is more common in ... Inherited Gene Elevates Prostate Cancer Risk in Affected Families Jan. 28, 2025 — The inherited mutated ...

[41] While negative reelin levels were found in prostate intraepithelial ... today's lengthened survival allows metastatic foci to become clinically apparent and cancer patients are more likely ...

There are self-care strategies that may aid in helping to prevent prostate cancer, the second most common cause of cancer-related death in men. Located below the bladder, the prostate is the gland ...